Login / Signup

Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.

Anke MothesM RunnebaumIngo B Runnebaum
Published in: Journal of cancer research and clinical oncology (2018)
Breast cancer survivors with atrophy-related complaints after pelvic floor surgery may benefit from vaginal application of this innovative dual protocol of Er:YAG laser technology as a non-hormonal treatment approach.
Keyphrases
  • minimally invasive
  • type diabetes
  • physical activity
  • combination therapy
  • high speed
  • replacement therapy